300K-funded Salamanca project evaluates freeze-dried blood for CLL
Summary
The University of Salamanca lists a CLL blood preservation validation project running from 1 December 2025 to 30 November 2026, led by Alberto Orfao and funded by 300K Solutions.
Source Date
Source checked
September 21, 2026
Event Type
validation_project
Event Date
December 1, 2025
Geography
Spain
Commercial Regulatory Status
Project scheduled through 30 November 2026; results and indication-specific regulatory status not established here
Related CFCM Topics
/market-intelligence /resources
Category
Company
Primary source
Read the source →Facts supported by cited sources
The University of Salamanca lists a CLL blood preservation validation project running from 1 December 2025 to 30 November 2026, led by Alberto Orfao and funded by 300K Solutions.
Claims Requiring Caution
University involvement is not evidence of financially independent validation.
A project listing does not demonstrate diagnostic equivalence or MRD performance.
The manufacturer announced an ESCCA symposium for 11 September; this announcement alone does not prove the presentation occurred.
Why It Matters
CFCM analysis: track published paired-sample validation before recommending clinical adoption.
An announcement is not proof of availability or authorisation. Interpret status within the stated jurisdiction and evidence boundary.
Editor and independence disclosure →